> this is a new drug being co-developed by Genentech and Novartis. It
> is an antibody that will block the effects of IgE which triggers the
> allergic response. It's still in clinical trials and more safety
> data has been requested from the FDA. There was a press release last
> week that they expect to submit a license application late this year
> or early next. The early clinical data has been quite good.
james here....
I asked my Allergist about this and he indicated it would only be for
Asthma. It is also an injection.
James
|
|  |
